Benefits
Cognitive function in older adults
One randomized, placebo-controlled trial in 90 adults aged 50 to 70 with age-associated memory impairment tested standardized spearmint extract (Neumentix®) at 900 mg/day or 600 mg/day against placebo for 90 days. At 900 mg/day, working memory quality improved 15 percent (p=0.0469) and spatial working memory accuracy improved 9 percent (p=0.0456). Both p-values are marginal, just under 0.05. Focus and reasoning were not among the outcomes that improved, and the 600 mg/day dose showed no significant cognitive improvement at all.
Reaction time and agility (uncited)
Uncited on this page. The reactive agility trial described below in recreationally active adults is not among this page's references, so nothing here supports a reaction time or attention claim in young adults or athletes. The one trial cited here enrolled adults aged 50 to 70.
Androgen levels in women with PCOS or hirsutism (spearmint tea, not this extract)
Uncited on this page. The 30-day trial described below is not among this page's references, it used spearmint tea rather than the standardized extract this page covers, and it enrolled women with a diagnosed medical condition. Nothing on this page supports taking spearmint extract to change hormone levels or hair growth. Anyone managing a diagnosed condition should work with their clinician.
Antioxidant activity (mechanism only, uncited)
Uncited on this page. Antioxidant scavenging and effects on inflammatory pathways come from laboratory work on spearmint polyphenols. No reference here measured antioxidant status or any inflammatory marker in people taking spearmint extract, so the link to the cognitive findings is an assumption rather than a result.
Digestive support (traditional use)
Traditional use for digestive comfort, such as gas and bloating, has limited modern clinical validation and is uncited on this page. Spearmint is common as a flavoring in digestive teas, but no trial referenced here measured a digestive outcome of any kind.
Mood support (preliminary)
Uncited on this page. The proposed anti-inflammatory effect on brain tissue was not measured in any referenced study, and no reference here reports mood as a verified outcome. This remains preliminary and is much less established than the single cognitive trial.
Form selection guidance
Spearmint tea is a traditional preparation and is not the product tested in this page's one reference. The standardized extract at 900 mg/day is the only form with a cited trial behind it, and even that trial found only two marginal cognitive improvements. Generic spearmint capsules at unknown standardization should not be assumed to produce the same result.
Mechanism of action
Acetylcholinesterase inhibition
Rosmarinic acid and related phenolics in spearmint inhibit acetylcholinesterase — the enzyme that degrades acetylcholine. That inhibition would in turn raise synaptic acetylcholine availability in circuits involved in learning and memory. It is a proposed mechanism only. Acetylcholinesterase activity was not measured in the single human trial cited on this page.
5-alpha reductase inhibition
Laboratory work suggests spearmint constituents can inhibit 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). No reference on this page measured this enzyme, any hormone level or any related outcome in people, so this is an unverified mechanism rather than an established effect.
Nrf2 antioxidant pathway activation
Rosmarinic acid activates the Nrf2-Keap1 pathway, inducing expression of cellular antioxidant and anti-inflammatory genes including HO-1, NQO1, and GPx. This pathway is offered as an explanation for the working memory changes seen in the 90-day trial, but Nrf2 activity and antioxidant gene expression were not measured in that trial.
Clinical trials
Randomized, double-blind, placebo-controlled trial of Neumentix® (900 mg/day, 600 mg/day, or placebo) in 90 healthy adults aged 50–70 with age-associated memory impairment for 90 days.
90 healthy adults aged 50–70. 90-day intervention.
At 900 mg/day, quality of working memory improved 15 percent versus placebo (p=0.0469), spatial working memory accuracy improved 9 percent (p=0.0456), and ability to fall asleep improved (p=0.0046). Both cognitive p-values are marginal, just under 0.05. The 600 mg/day dose showed no significant cognitive improvement. No adverse events were reported.
Randomized, double-blind, placebo-controlled, parallel trial of Neumentix® (900 mg/day) vs placebo in 142 healthy, recreationally active men and women for 90 days.
142 healthy active adults. 90-day intervention.
Significant improvements in reactive agility, with increases in number of correct hits and reductions in average reaction time on the Makoto Arena II audio-visual choice reaction test. This trial is not among this page's references, so its design, sample size and results could not be verified here and should not be read as established.
Two-center, 30-day randomized controlled trial of spearmint herbal tea (twice daily) vs. placebo herbal tea in 42 women with PCOS and hirsutism. Note: this trial used spearmint tea, not the patented Neumentix® extract, and it is not among this page's references. PCOS is a diagnosed medical condition; the trial is described here for context only, not as a reason to take a supplement.
42 women with PCOS. 1-month intervention.
Spearmint significantly reduced free and total testosterone in the spearmint tea group over 30 days (p<0.05), while LH and FSH increased (p<0.05). Subjective hirsutism scores improved on the Dermatology Quality of Life Index (p<0.05); objective Ferriman-Galwey scores trended toward improvement but did not reach significance — likely due to short study duration relative to hair growth cycles.